Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians
- 1 August 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Pharmacogenetics
- Vol. 8 (4) , 325-333
- https://doi.org/10.1097/00008571-199808000-00006
Abstract
The ability to metabolize CYP2D6 substrates sparteine, debrisoquine, and dextromethorphan was studied in healthy Caucasian (n=20), Ghanaian (n=21), and Chinese (n=22) CYP2D6 extensive metabolizers. Genotype analysis for the CYP2D6*1, *3, *4, *5, *9, *10, and *17 alleles was performed. Interethnic differences in the disposition of the probe drugs were found among the extensive metabolizers; extensive metabolizer status was confirmed by phenotype and genotype analysis. The mean metabolic rate was lower for Caucasians than for Ghanaians for sparteine (PPKeywords
This publication has 0 references indexed in Scilit: